Browsing: biomarker

News biomarker-alzheimers-brain

Researchers have analyzed flotillin levels in samples from individuals with and without Alzheimer’s disease (AD) and determined that serum flotillin levels are negatively associated with brain amyloid deposition. Flotillin could serve as a biomarker to estimate brain amyloid deposition, potentially aiding the early diagnosis of AD.

News brain-tumor-diagnostic-tool

Matthew Baker, University of Strathclyde (Glasgow, Scotland), led research for a diagnostic tool that distinguished 87% of blood samples from patients with brain cancer from healthy individuals. This diagnostic tool could improve the speed and accuracy of brain cancer diagnosis.

1 2 3 8